Patents by Inventor Chihaya Imai
Chihaya Imai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20180118845Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: ApplicationFiled: December 11, 2017Publication date: May 3, 2018Inventors: Dario Campana, Chihaya Imai
-
Publication number: 20180057563Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: ApplicationFiled: November 3, 2017Publication date: March 1, 2018Inventors: Dario Campana, Chihaya Imai
-
Patent number: 9856322Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: GrantFiled: June 12, 2014Date of Patent: January 2, 2018Assignee: St Jude Children's Research Hospital, Inc.Inventors: Dario Campana, Chihaya Imai
-
Patent number: 9834590Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: GrantFiled: October 1, 2015Date of Patent: December 5, 2017Assignee: St. Jude Children's Research Hospital, Inc.Inventors: Dario Campana, Chihaya Imai
-
Publication number: 20170283482Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: ApplicationFiled: March 27, 2017Publication date: October 5, 2017Inventors: Dario Campana, Chihaya Imai
-
Patent number: 9746951Abstract: A touch-sensitive vehicle display device is disclosed. The touch-sensitive vehicle display device comprises a body having a display including a touch panel on a surface thereof, whereby a screen operation is performed on the surface of the display by a touch-screen operation; an operation plate provided along the surface of the display; and a controller controlling information to be indicated on the display. The operation plate includes an opening section to indicate a switch provided to face the touch panel, and a plurality of touch-sensitive switch-confirmation portions provided on an end portion of the opening section for switch indication, and the controller controls a switch-indication portion to be inside the opening section to indicate switching in the display, and controls a plurality of selection-switches to be in the switch-indication portion to correspond to the plurality of switch-confirmation portions.Type: GrantFiled: October 26, 2015Date of Patent: August 29, 2017Assignee: CALSONIC KANSEI CORPORATIONInventor: Chihaya Imai
-
Patent number: 9684392Abstract: Provided is an in-car operation display device which improves the operability of a display unit. The display unit is used for indications and operations for car-installed functions such as settings and instructions of the car-installed functions. An operating means (first switch plate SpL, second switch plate SpR) includes an operating-plate portion (6L, 6R) configured to be operated to move along a display screen 5a of a display unit 5. The operating-plate portion (6L, 6R) includes a protruding switch portion (touch-sensor protrusion 10-15).Type: GrantFiled: April 12, 2013Date of Patent: June 20, 2017Assignee: CALSONIC KANSEI CORPORATIONInventors: Hideaki Kamiyama, Masaharu Haginoya, Chihaya Imai
-
Patent number: 9605049Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: GrantFiled: June 10, 2014Date of Patent: March 28, 2017Assignee: St. Jude Children's Research Hospital, Inc.Inventors: Dario Campana, Chihaya Imai
-
Publication number: 20160041671Abstract: A touch-sensitive vehicle display device is disclosed. The touch-sensitive vehicle display device comprises a body having a display including a touch panel on a surface thereof, whereby a screen operation is performed on the surface of the display by a touch-screen operation; an operation plate provided along the surface of the display; and a controller controlling information to be indicated on the display. The operation plate includes an opening section to indicate a switch provided to face the touch panel, and a plurality of touch-sensitive switch-confirmation portions provided on an end portion of the opening section for switch indication, and the controller controls a switch-indication portion to be inside the opening section to indicate switching in the display, and controls a plurality of selection-switches to be in the switch-indication portion to correspond to the plurality of switch-confirmation portions.Type: ApplicationFiled: October 26, 2015Publication date: February 11, 2016Inventor: Chihaya IMAI
-
Publication number: 20160009784Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: ApplicationFiled: October 1, 2015Publication date: January 14, 2016Inventors: Dario Campana, Chihaya Imai
-
Patent number: 9201536Abstract: A touch-sensitive vehicle display device is disclosed. The touch-sensitive vehicle display device comprises a body having a display including a touch panel on a surface thereof, whereby a screen operation is performed on the surface of the display by a touch-screen operation; an operation plate provided along the surface of the display; and a controller controlling information to be indicated on the display. The operation plate includes an opening section to indicate a switch provided to face the touch panel, and a plurality of touch-sensitive switch-confirmation portions provided on an end portion of the opening section for switch indication, and the controller controls a switch-indication portion to be inside the opening section to indicate switching in the display, and controls a plurality of selection-switches to be in the switch-indication portion to correspond to the plurality of switch-confirmation portions.Type: GrantFiled: May 16, 2014Date of Patent: December 1, 2015Assignee: CALSONIC KANSEI CORPORATIONInventor: Chihaya Imai
-
Publication number: 20150084886Abstract: Provided is an in-car operation display device which improves the operability of a display unit. The display unit is used for indications and operations for car-installed functions such as settings and instructions of the car-installed functions. An operating means (first switch plate SpL, second switch plate SpR) includes an operating-plate portion (6L, 6R) configured to be operated to move along a display screen 5a of a display unit 5. The operating-plate portion (6L, 6R) includes a protruding switch portion (touch-sensor protrusion 10-15).Type: ApplicationFiled: April 12, 2013Publication date: March 26, 2015Applicant: CALSONIC KANSEI CORPORATIONInventors: Hideaki Kamiyama, Masaharu Haginoya, Chihaya Imai
-
Publication number: 20140350784Abstract: A touch-sensitive vehicle display device is disclosed. The touch-sensitive vehicle display device comprises a body having a display including a touch panel on a surface thereof, whereby a screen operation is performed on the surface of the display by a touch-screen operation; an operation plate provided along the surface of the display; and a controller controlling information to be indicated on the display. The operation plate includes an opening section to indicate a switch provided to face the touch panel, and a plurality of touch-sensitive switch-confirmation portions provided on an end portion of the opening section for switch indication, and the controller controls a switch-indication portion to be inside the opening section to indicate switching in the display, and controls a plurality of selection-switches to be in the switch-indication portion to correspond to the plurality of switch-confirmation portions.Type: ApplicationFiled: May 16, 2014Publication date: November 27, 2014Applicant: CALSONIC KANSEI CORPORATIONInventor: Chihaya IMAI
-
Publication number: 20140341869Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: ApplicationFiled: June 10, 2014Publication date: November 20, 2014Inventors: Dario Campana, Chihaya Imai
-
Publication number: 20140328812Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: ApplicationFiled: June 12, 2014Publication date: November 6, 2014Inventors: Dario Campana, Chihaya Imai
-
Publication number: 20130266551Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: ApplicationFiled: March 14, 2013Publication date: October 10, 2013Inventors: DARIO CAMPANA, CHIHAYA IMAI
-
Patent number: 8399645Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: GrantFiled: July 12, 2012Date of Patent: March 19, 2013Assignee: St. Jude Children's Research Hospital, Inc.Inventors: Dario Campana, Chihaya Imai
-
Publication number: 20120282256Abstract: The present invention relates to a chimeric receptor capable of signaling both a primary and a co-stimulatory pathway, thus allowing activation of the co-stimulatory pathway without binding to the natural ligand. The cytoplasmic domain of the receptor contains a portion of the 4-1BB signaling domain. Embodiments of the invention relate to polynucleotides that encode the receptor, vectors and host cells encoding a chimeric receptor, particularly including T cells and natural killer (NK) cells and methods of use.Type: ApplicationFiled: July 12, 2012Publication date: November 8, 2012Applicant: St. Jude Children's Research Hospital, Inc.Inventors: Dario CAMPANA, Chihaya Imai
-
Publication number: 20120015434Abstract: The present invention relates to novel methods for preferentially activating and expanding NK cells. The methods utilize the stimulatory effects of IL-15 and CD137 ligand to preferentially expand and activate NK cells in a mixed cell culture comprising NK cells.Type: ApplicationFiled: September 26, 2011Publication date: January 19, 2012Applicant: St. Jude Children's Research HospitalInventors: Dario Campana, Chihaya Imai
-
Patent number: 8026097Abstract: The present invention relates to novel methods for preferentially activating and expanding NK cells. The methods utilize the stimulatory effects of IL-15 and CD137 ligand to preferentially expand and activate NK cells in a mixed cell culture comprising NK cells.Type: GrantFiled: September 8, 2008Date of Patent: September 27, 2011Assignee: St. Jude Children's Research HospitalInventors: Dario Campana, Chihaya Imai